Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 239Carcinoma, Non-Small-Cell Lung 237Prostatic Neoplasms 172Multiple Myeloma 154Neoplasms 136Colorectal Neoplasms 127Leukemia, Myeloid, Acute 123Lung Neoplasms 110Neoplasm Metastasis 101Squamous Cell Carcinoma of Head and Neck 94Carcinoma, Hepatocellular 91Melanoma 89Lymphoma 85Triple Negative Breast Neoplasms 77Pancreatic Neoplasms 77Ovarian Neoplasms 72Sarcoma 71Carcinoma, Renal Cell 66Brain Neoplasms 66Lymphoma, Large B-Cell, Diffuse 65Recurrence 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Head and Neck Neoplasms 57Lymphoma, Non-Hodgkin 56Leukemia, Lymphocytic, Chronic, B-Cell 55Stomach Neoplasms 54Hematologic Neoplasms 53Endometrial Neoplasms 53Urinary Bladder Neoplasms 51Small Cell Lung Carcinoma 50

Interventions

fluoromisonidazole 1Taxes 1Radiation 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Stage III Lung Non-Small Cell Cancer AJCC v7 × 90 days × Clear all
NCT01507428 2026-04-21

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
138 enrolled 42 charts

Stage III Lung Non-Small Cell Cancer AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡